Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial

BACKGROUND: Increasing levels of antibiotic resistance have reduced the Helicobacter pylori (H. pylori) eradication rates afforded by the standard triple therapy. Thus, 2-wk first-line four-drug regimens must be considered. AIM: To analyze the eradication rates of modified bismuth-containing quadrup...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, So Jeong, Chung, Jun-Won, Woo, Hyun Sun, Kim, Su Young, Kim, Jung Ho, Kim, Yoon Jae, Kim, Kyoung Oh, Kwon, Kwang An, Park, Dong Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920663/
https://www.ncbi.nlm.nih.gov/pubmed/31857780
http://dx.doi.org/10.3748/wjg.v25.i46.6790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920663/
https://www.ncbi.nlm.nih.gov/pubmed/31857780
http://dx.doi.org/10.3748/wjg.v25.i46.6790

Ejemplares similares